Seminars in Liver Disease
Issue 04 · Volume 44 · November 2024
Review Article
de Jong, Ype P.:
Meena, Babu Lal; Sarin, Shiv Kumar:
Sethi, Namya; Khokhar, Manoj; Mathur, Mitali; Batra, Yashi; Mohandas, Amal; Tomo, Sojit; Rao, Mahadev; Banerjee, Mithu:
Therapeutic Potential of Nutraceuticals against Drug-Induced Liver Injury
Maher, Salim; Rajapakse, Jayashi; El-Omar, Emad; Zekry, Amany:
Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease
Mak, Lung-Yi; Boettler, Tobias; Gill, Upkar S.:
HBV Biomarkers and Their Role in Guiding Treatment Decisions
Pompili, Enrico; Iannone, Giulia; Carrello, Daniele; Zaccherini, Giacomo; Baldassarre, Maurizio; Caraceni, Paolo:
Managing Multiorgan Failure in Acute on Chronic Liver Failure
Prado, Luan G.; Nagy, Laura E.:
About the Journal
Seminars in Liver Disease
Seminars in Liver Disease为每季度一期,出版与肝脏病学和胃肠病学专业相关话题的综述论文。
作为该领域的重要的综述期刊,Seminars in Liver Disease 在基础、转化和临床肝病学领域提供了各种不同主题的深入报道。来自专家的邀请综述涵盖了成人和儿童群体的疾病发病机制、诊断、分类和管理方面进展的重要和即时的主题。临床方面的一些重要主题包括NAFLD、ALD、胆管病、病毒性肝炎、肝硬化、移植、血管和凝血障碍、自身免疫性肝炎、DILI、卟啉症、HCC、肝肿瘤、遗传疾病等。基础肝病学的一些主题包括肝脏发育、再生、细胞可塑性、信号通路、瘤形成、新技术进步、动物模型、类器官等。
Seminars in Liver Disease 仅发表约稿综述,个别情况下,也会考虑特殊性质的非约稿综述,但不会发表病例报告和原创论文。所有综述论文在最终接受和发表之前都经过严格的评审过程。